Drug Type Chemical drugs |
Synonyms TBK1/IKKε inhibitor(Domainex) |
Target |
Mechanism IKKε inhibitors(inhibitor of nuclear factor kappa B kinase subunit epsilon inhibitors), TBK1 inhibitors(Serine/threonine-protein kinase TBK1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | GB | 14 Sep 2022 |